Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Lasers can help reduce skin side effects from cancer treatment.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

EGFR helps protect hair follicles from damage and scarring.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

EGFR is essential for organized skin nerve growth and branching.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Gefitinib can cause scalp skin issues and permanent hair loss.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

EGF receptors are crucial for skin cell growth and decrease with age.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Erlotinib can cause excessive eyelash growth.